Surfix Announces Nadieh Kuijpers as Chief Commercial Officer

We are delighted to welcome Nadieh Kuijpers to our team as the new Chief Commercial Officer. Nadieh brings extensive market knowledge and commercial expertise from the Life Sciences industry, which will be invaluable as we continue to grow our business in the coming years.

On August 5th, Nadieh Kuijpers officially joined Surfix Diagnostics as CCO.

Surfix's photonic diagnostics platform is multi-modal, capable of serving a wide range of Point-of-Care applications for both protein-based and molecular biomarkers. As a rapidly growing startup, our focus is on strategic partnerships for co-developing immunoassays with diagnostic, biomarker discovery, and biopharmaceutical companies first and adding our molecular and combined capabilities at a later stage.

Nadieh's appointment marks a significant milestone for our company. With a proven track record in the Life Sciences industry and diagnostic partnerships, she is well-equipped to drive our commercial success. Nadieh holds a Master's degree in Biomedical Sciences from Utrecht University and brings a wealth of laboratory and commercial experience within the Life Sciences and diagnostics field.